The rate of progression of liver disease from NAFLD to fibrosis is higher among patients with elevated blood glucose levels, which can be attributed to excess AGEs and RAGE production among these groups of patients [44, 45]. The gene discussed is AGER; the disease is metabolic dysfunction-associated steatotic liver disease.